Faculty profile

Kevin Bainey

ResearcherMedicineUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses and email address may be missing. Find their university profile.

Kevin Bainey

Researcher

Medicine

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
13 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 3 research grants (3 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Beta-Blockers Myocardial Infarction Pragmatic Clinical Trial Stable Ischemic Heart Disease Artificial Intelligence Electrocardiogram Mortality Population Health

Latest papers

Defining Population at Risk and Assessment of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction
Canadian Journal of Cardiology · 2026
A Standardized Invasive Protocol for the Investigation of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction
Canadian Journal of Cardiology · 2026
Defining Metrics and the Framework for the Invasive Assessment of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction
Canadian Journal of Cardiology · 2026

All 17 publications

Latest funding

Evaluation of an asPirin-free strAtegy with ticagrelor in patieNts wiTH acutE corONary syndrome treated medically: the PANTHEON randomized controlled trial
CIHR · 2024 · Principal investigator
$6,972,975
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
CIHR · 2023 · Principal investigator
The EXamining Population-Level mORtality from the Electrocardiogram using Artificial Intelligence (EXPLORE-AI) Study
CIHR · 2021 · Principal investigator
$596,700

All 6 grants and awards

17 publications.

Defining Population at Risk and Assessment of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction

Boivin-Proulx L-A, Schampaert E, Bainey K, Chong AY, Saw J, Eckstein J, Lavoie A, Abuzeid W, Schwalm JD, Lara TAC

Canadian Journal of Cardiology20262 citations

DOI: 10.1016/j.cjca.2025.12.062

A Standardized Invasive Protocol for the Investigation of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction

Boivin-Proulx L-A, Schampaert E, Bainey K, Chong AY, Saw J, Eckstein J, Lavoie A, Abuzeid W, Schwalm JD, Lara TAC

Canadian Journal of Cardiology20261 citations

DOI: 10.1016/j.cjca.2026.01.034

Defining Metrics and the Framework for the Invasive Assessment of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction

Boivin-Proulx L-A, Schampaert E, Bainey K, Chong AY, Saw J, Eckstein J, Lavoie A, Abuzeid W, Schwalm JD, Lara TAC

Canadian Journal of Cardiology20261 citations

DOI: 10.1016/j.cjca.2025.12.061

Transfusion-related adverse events in patients with restrictive or liberal transfusion strategy. An analysis of the MINT trial.

Ghafghazi S, Uhl L, Herbert B, Bertolet M, Alexander JH, Goodman SG, Raval J, Roubille F, Fordyce CB, Goldfarb M, Bainey K, de Andrade PB, Senaratne J, Bracey A, Roswell RO, Lopes R, Simon T, Steg G, Brooks MM, Hebert PC, Carson JL, Triulizi DJ, MINT Trial Investigators

Transfusion2026

DOI: 10.1111/trf.70006 PMID: 41305907

Timeliness of reperfusion in ST-segment elevation myocardial infarction and outcomes in Kerala, India: results of the TRUST outcomes registry.

Mathew A, Moolla M, Jeemon P, Punnoose E, Ashraf SM, Pisharody S, Viswanathan S, Jayakumar TG, Jabir A, Mathew JP, John T, Thomas V, Bainey K

Postgraduate medical journal2025Senior author

DOI: 10.1093/postmj/qgae129 PMID: 39362656

Intravascular Imaging in the Diagnosis and Management of Patients With Suspected Intracoronary Pathologies: A CJC White Paper

group W, Sibbald M, Cioffi GM, Shenouda M, McGrath B, Elbarouni B, Har B, Akl E, Schampaert E, Bishop H

Canadian Journal of Cardiology20246 citations

DOI: 10.1016/j.cjca.2024.05.021

Hospital and Physician Variability in Revascularization Decisions and Outcomes for Patients With 3-Vessel and Left Main Coronary Artery Disease: A Population-Based Cohort Study.

Wilson T, James MT, Southern D, Har B, Graham MM, Brass N, Bainey K, Fedak PWM, Sajobi TT, Wilton SB

Journal of the American Heart Association2024

DOI: 10.1161/jaha.123.035356 PMID: 39248266

Development and validation of machine learning algorithms based on electrocardiograms for cardiovascular diagnoses at the population level.

Kalmady SV, Salimi A, Sun W, Sepehrvand N, Nademi Y, Bainey K, Ezekowitz J, Hindle A, McAlister F, Greiner R, Sandhu R, Kaul P

NPJ digital medicine2024

DOI: 10.1038/s41746-024-01130-8 PMID: 38762623

Coronary Artery Fistula: A Diagnostic Dilemma.

Kumar R, Kumar J, O'Connor C, Ullah I, Tyrell B, Pearson I, Matiullah S, Bainey K

Interventional cardiology (London, England)2023Senior author

DOI: 10.15420/icr.2022.34 PMID: 38125927

Increased Classical Monocytes in South Asian Compared With White Caucasian Individuals at Risk for Coronary Atherosclerosis.

Hosseini F, Franco C, Whalen BA, Taylor CM, Sellers SL, Khan N, Kaila K, Bainey K, Farkouh M, Gupta M, Verma S, Ramanathan K

The Canadian journal of cardiology2023

DOI: 10.1016/j.cjca.2023.07.028 PMID: 37517476

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2024

Subject: Prospective PhD student: Beta-Blockers Dear Professor Bainey, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Defining Population at Risk and Assessment of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Evaluation of an asPirin-free strAtegy with ticagrelor in patieNts wiTH acutE corONary syndrome treated medically: the PANTHEON randomized controlled trial" (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Kevin Bainey

Research

Latest papers

Latest funding

Defining Population at Risk and Assessment of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction

A Standardized Invasive Protocol for the Investigation of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction

Defining Metrics and the Framework for the Invasive Assessment of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction

Transfusion-related adverse events in patients with restrictive or liberal transfusion strategy. An analysis of the MINT trial.

Timeliness of reperfusion in ST-segment elevation myocardial infarction and outcomes in Kerala, India: results of the TRUST outcomes registry.

Intravascular Imaging in the Diagnosis and Management of Patients With Suspected Intracoronary Pathologies: A CJC White Paper

Hospital and Physician Variability in Revascularization Decisions and Outcomes for Patients With 3-Vessel and Left Main Coronary Artery Disease: A Population-Based Cohort Study.

Development and validation of machine learning algorithms based on electrocardiograms for cardiovascular diagnoses at the population level.

Coronary Artery Fistula: A Diagnostic Dilemma.

Increased Classical Monocytes in South Asian Compared With White Caucasian Individuals at Risk for Coronary Atherosclerosis.

Evaluation of an asPirin-free strAtegy with ticagrelor in patieNts wiTH acutE corONary syndrome treated medically: the PANTHEON randomized controlled trial

De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)

The EXamining Population-Level mORtality from the Electrocardiogram using Artificial Intelligence (EXPLORE-AI) Study

COMPLETE-2: A prospective, randomized, multi-centre trial of physiology-guided versus angiography-guided complete revascularization to treat multivessel disease after early percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Improving Canadian Outcomes Research On the Novel SARS-CoV-2 using Analytics: the CORONA Consortium

COMPLETE Trial: Complete revascularization versus optimal medical therapy to treat residual multi-vessel disease in patients with ST-segment elevation myocardial infarction.

Frequent collaborators

Cedric Manlhiot

Jacqueline Saw

Jon-david Schwalm

Abram Hindle

Bryan Har

Roopinder Sandhu

Michael Goldfarb

Russell Greiner

Sean van Diepen

Andre Lamy

Natalia Pinilla-Echeverri

Matthew Sibbald

Tej Sheth

Elie Akl

Justin Ezekowitz

Nadia Khan

Subodh Verma

Michael Farkouh

Samer Mansour

Finlay Mcalister

Shamir Mehta

Amiram Jacob Gafni